Cite
HARVARD Citation
Chan, O. et al. (2021). Can Quantitative Measures of T790M Allelic Fraction Predict Survival Outcomes in Patients Receiving Osimertinib? Observations From an Early Access Programme. Clinical oncology. 33 (7), pp. e305-e314. [Online].